Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury

Published:2011-11-11 Issue:1 Volume:97 Page:89-101
ISSN:0958-0670
Container-title:Experimental Physiology
language:en
Short-container-title:

Author:

Qi Yanfei,Li Hongwei,Shenoy Vinayak,Li Qiuhong,Wong Fong,Zhang Ling,Raizada Mohan K.,Sumners Colin,Katovich Michael J.

Publisher

Wiley

Subject

Physiology,Physiology (medical),Nutrition and Dietetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1113/expphysiol.2011.060673/fullpdf

Reference49 articles.

1. Angiotensin II receptor blockade and ventricular remodelling;Anavekar;J Renin Angiotensin Aldosterone Syst,2005

2. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy;Booz;Hypertension,1996

3. Paracrine actions of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin-angiotensin system;Booz;Am J Cardiol,1999

4. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart;Castro;Hypertension,2005

5. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy;D’Amore;Hypertension,2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling;Biochemical Pharmacology;2024-04

2. Evolving views on the first two ligands of the angiotensin II type 2 receptor. From putative antagonists to potential agonists?;European Journal of Pharmacology;2023-12

3. Catch your breath: The protective role of the angiotensin AT2 receptor for the treatment of idiopathic pulmonary fibrosis;Biochemical Pharmacology;2023-11

4. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies;Cancer Cell International;2023-10-27

5. Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine;Scientific Reports;2023-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3